Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future...
-
Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and...
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Brain Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
-
4D Path to participate as exploratory biomarker collaborator in Phase II DAD-IO clinical study (NCT04724018) led by DFCI and supported by Gilead Sciences
-
4D Path has announced a collaboration with AMD and Oracle to advance predictive oncology and accelerate clinical trials.
-
Dublin, Dec. 09, 2025 (GLOBE NEWSWIRE) -- The "DNA Diagnostics Market - Global Outlook & Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering.The DNA Diagnostics Market was...
-
Trial analysis published in JNCI predicts residual cancer burden from baseline H&E slides using 4D Path's fully automated, treatment predictive platform
-
Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market - Technologies, Applications and End-Use Facilities" has been added to ResearchAndMarkets.com's offering.The cutting-edge...